{"id":31812,"date":"2019-02-12T12:00:00","date_gmt":"2019-02-12T12:00:00","guid":{"rendered":"https:\/\/www.euforea.org\/news\/was-sind-die-herausforderungen-oder-chancen-fuer-die-einfuehrung-der-ait\/"},"modified":"2019-02-12T12:00:00","modified_gmt":"2019-02-12T12:00:00","slug":"was-sind-die-herausforderungen-oder-chancen-fuer-die-einfuehrung-der-ait","status":"publish","type":"news","link":"https:\/\/www.euforea.org\/de\/news\/was-sind-die-herausforderungen-oder-chancen-fuer-die-einfuehrung-der-ait\/","title":{"rendered":"Was sind die Herausforderungen oder Chancen f\u00fcr die Einf\u00fchrung der AIT?"},"content":{"rendered":"<div class=\"paragraph paragraph--text-columns paragraph-id--1439 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<h2>Rhinology Future Debates Br\u00fcssel 2018<\/h2>\n<p>In diesem Video diskutieren unsere Diskussionsteilnehmer \u00fcber die Einf\u00fchrung der Allergen-Immuntherapie durch die Implementierung von Change-Management-Strategien, da die Allergen-Immuntherapie bei allergischer Rhinitis und Asthma hochwirksam ist. Erfahren Sie mehr \u00fcber die Barrieren oder Chancen bei der Einf\u00fchrung der Therapie. <\/p>\n<h3>Podiumsteilnehmende<\/h3>\n<p>Claus Bachert, Jean Bousquet, Mohamed Shamji, Walter Canonica, AIT-Patientenvertreter.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"paragraph paragraph--text-columns paragraph-id--1440 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<div class=\"video-container\"><center><iframe title=\"YouTube-Videoplayer\" src=\"https:\/\/www.youtube.com\/embed\/mmEs-ju-OSQ?rel=0\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/center><\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Rhinology Future Debates Br\u00fcssel 2018 In diesem Video diskutieren unsere Diskussionsteilnehmer \u00fcber die Einf\u00fchrung der Allergen-Immuntherapie durch die Implementierung von Change-Management-Strategien, da die Allergen-Immuntherapie bei allergischer Rhinitis und Asthma hochwirksam ist. Erfahren Sie mehr \u00fcber die Barrieren oder Chancen bei der Einf\u00fchrung der Therapie. Podiumsteilnehmende Claus Bachert, Jean Bousquet, Mohamed Shamji, Walter Canonica, AIT-Patientenvertreter.<\/p>\n","protected":false},"author":1,"featured_media":31832,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[182],"tags":[183,184,185],"class_list":["post-31812","news","type-news","status-publish","has-post-thumbnail","hentry","category-rhinology-future-debates","tag-rhinologie","tag-debatten","tag-rhinology-future-debates"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.3 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Was sind die Herausforderungen oder Chancen f\u00fcr die Einf\u00fchrung der AIT? - EUFOREA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.euforea.org\/de\/news\/was-sind-die-herausforderungen-oder-chancen-fuer-die-einfuehrung-der-ait\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Was sind die Herausforderungen oder Chancen f\u00fcr die Einf\u00fchrung der AIT?\" \/>\n<meta property=\"og:description\" content=\"Rhinology Future Debates Br\u00fcssel 2018 In diesem Video diskutieren unsere Diskussionsteilnehmer \u00fcber die Einf\u00fchrung der Allergen-Immuntherapie durch die Implementierung von Change-Management-Strategien, da die Allergen-Immuntherapie bei allergischer Rhinitis und Asthma hochwirksam ist. Erfahren Sie mehr \u00fcber die Barrieren oder Chancen bei der Einf\u00fchrung der Therapie. Podiumsteilnehmende Claus Bachert, Jean Bousquet, Mohamed Shamji, Walter Canonica, AIT-Patientenvertreter.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.euforea.org\/de\/news\/was-sind-die-herausforderungen-oder-chancen-fuer-die-einfuehrung-der-ait\/\" \/>\n<meta property=\"og:site_name\" content=\"EUFOREA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/euforea\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@euforea\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/de\\\/news\\\/was-sind-die-herausforderungen-oder-chancen-fuer-die-einfuehrung-der-ait\\\/\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/de\\\/news\\\/was-sind-die-herausforderungen-oder-chancen-fuer-die-einfuehrung-der-ait\\\/\",\"name\":\"Was sind die Herausforderungen oder Chancen f\u00fcr die Einf\u00fchrung der AIT? - EUFOREA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/de\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/de\\\/news\\\/was-sind-die-herausforderungen-oder-chancen-fuer-die-einfuehrung-der-ait\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/de\\\/news\\\/was-sind-die-herausforderungen-oder-chancen-fuer-die-einfuehrung-der-ait\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Rhinology20Future20Debates202018_3.png\",\"datePublished\":\"2019-02-12T12:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/de\\\/news\\\/was-sind-die-herausforderungen-oder-chancen-fuer-die-einfuehrung-der-ait\\\/#breadcrumb\"},\"inLanguage\":\"de-DE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.euforea.org\\\/de\\\/news\\\/was-sind-die-herausforderungen-oder-chancen-fuer-die-einfuehrung-der-ait\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de-DE\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/de\\\/news\\\/was-sind-die-herausforderungen-oder-chancen-fuer-die-einfuehrung-der-ait\\\/#primaryimage\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Rhinology20Future20Debates202018_3.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Rhinology20Future20Debates202018_3.png\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/de\\\/news\\\/was-sind-die-herausforderungen-oder-chancen-fuer-die-einfuehrung-der-ait\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/de\\\/waehlen-sie-ihren-weg\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/de\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Was sind die Herausforderungen oder Chancen f\u00fcr die Einf\u00fchrung der AIT?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/de\\\/#website\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/de\\\/\",\"name\":\"EUFOREA\",\"description\":\"Inspiring the Future of Respiratory Care\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/de\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.euforea.org\\\/de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de-DE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/de\\\/#organization\",\"name\":\"EUFOREA\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/de\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de-DE\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/de\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"width\":500,\"height\":500,\"caption\":\"EUFOREA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/de\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/euforea\\\/\",\"https:\\\/\\\/x.com\\\/euforea\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/euforea\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/EUFOREA\",\"https:\\\/\\\/www.instagram.com\\\/euforeaofficial\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Was sind die Herausforderungen oder Chancen f\u00fcr die Einf\u00fchrung der AIT? - EUFOREA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.euforea.org\/de\/news\/was-sind-die-herausforderungen-oder-chancen-fuer-die-einfuehrung-der-ait\/","og_locale":"de_DE","og_type":"article","og_title":"Was sind die Herausforderungen oder Chancen f\u00fcr die Einf\u00fchrung der AIT?","og_description":"Rhinology Future Debates Br\u00fcssel 2018 In diesem Video diskutieren unsere Diskussionsteilnehmer \u00fcber die Einf\u00fchrung der Allergen-Immuntherapie durch die Implementierung von Change-Management-Strategien, da die Allergen-Immuntherapie bei allergischer Rhinitis und Asthma hochwirksam ist. Erfahren Sie mehr \u00fcber die Barrieren oder Chancen bei der Einf\u00fchrung der Therapie. Podiumsteilnehmende Claus Bachert, Jean Bousquet, Mohamed Shamji, Walter Canonica, AIT-Patientenvertreter.","og_url":"https:\/\/www.euforea.org\/de\/news\/was-sind-die-herausforderungen-oder-chancen-fuer-die-einfuehrung-der-ait\/","og_site_name":"EUFOREA","article_publisher":"https:\/\/www.facebook.com\/euforea\/","twitter_card":"summary_large_image","twitter_site":"@euforea","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.euforea.org\/de\/news\/was-sind-die-herausforderungen-oder-chancen-fuer-die-einfuehrung-der-ait\/","url":"https:\/\/www.euforea.org\/de\/news\/was-sind-die-herausforderungen-oder-chancen-fuer-die-einfuehrung-der-ait\/","name":"Was sind die Herausforderungen oder Chancen f\u00fcr die Einf\u00fchrung der AIT? - EUFOREA","isPartOf":{"@id":"https:\/\/www.euforea.org\/de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.euforea.org\/de\/news\/was-sind-die-herausforderungen-oder-chancen-fuer-die-einfuehrung-der-ait\/#primaryimage"},"image":{"@id":"https:\/\/www.euforea.org\/de\/news\/was-sind-die-herausforderungen-oder-chancen-fuer-die-einfuehrung-der-ait\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202018_3.png","datePublished":"2019-02-12T12:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.euforea.org\/de\/news\/was-sind-die-herausforderungen-oder-chancen-fuer-die-einfuehrung-der-ait\/#breadcrumb"},"inLanguage":"de-DE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.euforea.org\/de\/news\/was-sind-die-herausforderungen-oder-chancen-fuer-die-einfuehrung-der-ait\/"]}]},{"@type":"ImageObject","inLanguage":"de-DE","@id":"https:\/\/www.euforea.org\/de\/news\/was-sind-die-herausforderungen-oder-chancen-fuer-die-einfuehrung-der-ait\/#primaryimage","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202018_3.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202018_3.png","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/www.euforea.org\/de\/news\/was-sind-die-herausforderungen-oder-chancen-fuer-die-einfuehrung-der-ait\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.euforea.org\/de\/waehlen-sie-ihren-weg\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.euforea.org\/de\/news\/"},{"@type":"ListItem","position":3,"name":"Was sind die Herausforderungen oder Chancen f\u00fcr die Einf\u00fchrung der AIT?"}]},{"@type":"WebSite","@id":"https:\/\/www.euforea.org\/de\/#website","url":"https:\/\/www.euforea.org\/de\/","name":"EUFOREA","description":"Inspiring the Future of Respiratory Care","publisher":{"@id":"https:\/\/www.euforea.org\/de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.euforea.org\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de-DE"},{"@type":"Organization","@id":"https:\/\/www.euforea.org\/de\/#organization","name":"EUFOREA","url":"https:\/\/www.euforea.org\/de\/","logo":{"@type":"ImageObject","inLanguage":"de-DE","@id":"https:\/\/www.euforea.org\/de\/#\/schema\/logo\/image\/","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","width":500,"height":500,"caption":"EUFOREA"},"image":{"@id":"https:\/\/www.euforea.org\/de\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/euforea\/","https:\/\/x.com\/euforea","https:\/\/www.linkedin.com\/company\/euforea","https:\/\/www.youtube.com\/c\/EUFOREA","https:\/\/www.instagram.com\/euforeaofficial\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.euforea.org\/de\/wp-json\/wp\/v2\/news\/31812","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euforea.org\/de\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.euforea.org\/de\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/de\/wp-json\/wp\/v2\/comments?post=31812"}],"version-history":[{"count":0,"href":"https:\/\/www.euforea.org\/de\/wp-json\/wp\/v2\/news\/31812\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/de\/wp-json\/wp\/v2\/media\/31832"}],"wp:attachment":[{"href":"https:\/\/www.euforea.org\/de\/wp-json\/wp\/v2\/media?parent=31812"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euforea.org\/de\/wp-json\/wp\/v2\/categories?post=31812"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euforea.org\/de\/wp-json\/wp\/v2\/tags?post=31812"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}